Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.

Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.
复制标题

葛根素抗2019冠状病毒病(COVID-19)的靶点和机制

DOI:
10.1111/jcmm.16117
复制
发表时间:
2021-01
影响因子:
5.3
通讯作者:
Li R
Li R
中科院分区:
医学2区
文献类型:
--
作者:
Qin X;Huang C;Wu K;Li Y;Liang X;Su M;Li R

文献摘要

参考文献

被引文献

相似文献

本研究旨在利用网络药理学和分子对接等计算机方法,揭示葛根素作为COVID - 19潜在治疗药物的药理作用和潜在机制。葛根素治疗COVID - 19的关键靶点包括表皮生长因子受体(EGFR)、肿瘤坏死因子(TNF)、肿瘤蛋白p53 (TP53)、caspase 3 (CASP3)、RELA原癌基因(RELA)、Fos原癌基因(Fos)、caspase 8 (CASP8)、前列腺素内过氧化物合成酶2 (PTGS2)、白细胞介素2 (IL2)、蛋白激酶CB (PRKCB)、B细胞淋巴瘤/白血病基因2 (BCL2)、蛋白激酶CA (PRKCA)、一氧化氮合酶3 (NOS3)和过氧化物酶体增殖物激活受体(PPARG)。在功能上,葛根素的抗covid - 19作用与抑制氧化应激和炎症级联反应以及细胞凋亡有关。葛根素治疗COVID - 19的信号通路包括调节细胞凋亡、IL - 17信号通路、丝裂原活化蛋白激酶(MAPK)信号通路和TNF信号通路。分子对接数据表明葛根素与COVID - 19的结合能力和有效的抗COVID - 19活性。综上所述,我们目前基于网络药理学的研究结果揭示了葛根素在治疗COVID - 19中的药理作用。此外,生物信息学研究结果表明,其中一些关键靶点可能作为检测COVID - 19的潜在分子标记。
The present study aimed to uncover the pharmacological function and underlying mechanism of puerarin as a potential treatment for COVID‐19, using an in silico methodology, including network pharmacology and molecular docking. The pivotal targets of puerarin to treat COVID‐19 were identified and included the epidermal growth factor receptor (EGFR), tumour necrosis factor (TNF), tumour protein p53 (TP53), caspase 3 (CASP3), RELA proto‐oncogene (RELA), Fos proto‐oncogene (FOS), caspase 8 (CASP8), prostaglandin‐endoperoxide synthase 2 (PTGS2), interleukin 2 (IL2), protein kinase CB (PRKCB), B cell lymphoma/leukaemia gene‐2 (BCL2), protein kinase CA (PRKCA), nitric oxide synthase 3 (NOS3) and peroxisome proliferator–activated receptor gamma (PPARG). Functionally, the anti–COVID‐19 action of puerarin was associated with the suppression of oxidative stress and inflammatory cascades, and cell apoptosis. The signalling pathways of puerarin to treat COVID‐19 included modulation of the pathways of apoptosis, IL‐17 signalling, mitogen‐activated protein kinase (MAPK) signalling and TNF signalling. Molecular docking data illustrated the binding capacity of puerarin with COVID‐19 and the effective anti–COVID‐19 activity of puerarin. Taken together, our current network pharmacology–based findings revealed the pharmacological role of puerarin in the treatment of COVID‐19. Furthermore, the bioinformatic findings elucidated that some of these pivotal targets might serve as potential molecular markers for detecting COVID‐19.
DOI: 10.1007/s00436-008-1277-9
发表时间: 2009-02-01
影响因子: 2
作者:
Derda, Monika;Hadas, Edward;Thiem, Barbara
通讯作者: Thiem, Barbara
DOI: 10.1093/bib/bbaa141
发表时间: 2021-03-01
影响因子: 9.5
作者:
Li, Rong;Wu, Ka;Chen, Jian
通讯作者: Chen, Jian
DOI: 10.1016/j.fct.2012.10.059
发表时间: 2013-02-01
影响因子: 4.3
作者:
Li, Rong;Xu, Lingyuan;Duan, Xiaoqun
通讯作者: Duan, Xiaoqun
DOI: 10.1016/j.jare.2019.05.003
发表时间: 2019-11-01
影响因子: 10.7
作者:
Wu, Ka;Wei, Pingyuan;Su, Min
通讯作者: Su, Min
DOI: 10.18632/aging.103886
发表时间: 2020-10-08
期刊: Aging
影响因子: --
作者:
Nong Y;Liang Y;Liang X;Li Y;Yang B
通讯作者: Yang B